Comparative efficacy and safety of three fixed‐ratio combination products in type 2 diabetes: A network meta‐analysis

Among the three fixed-ratio combination products, IDegLira appears most effective for glycemic control (in terms of HbA1c and FPG reduction), whereas IDegAsp demonstrates the best safety profile regarding incidence of TEAEs.

Authors

Xianying Wang
Jiali Qin
Yang Liu
Xiaomei Wang

Institutions

Hebei Medical University (CN)
Third Hospital of Hebei Medical University (CN)

Publication Details

Journal: Journal of Diabetes Investigation
Published: 2026-03-28
DOI: https://doi.org/10.1111/jdi.70293
Primary Topic: Diabetes Treatment and Management
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Comparative efficacy and safety of three fixed‐ratio combination products in type 2 diabetes: A network meta‐analysis

Xianying Wang, Jiali Qin, Yang Liu, Xiaomei Wang

Mar 28, 2026

Journal of Diabetes Investigation

Diabetes Treatment and Management

article

Comparative efficacy and safety of three fixed‐ratio combination products in type 2 diabetes: A network meta‐analysis

Xianying Wang, Jiali Qin, Yang Liu, Xiaomei Wang

March 28, 2026article en

Abstract

Journal of Diabetes Investigation

Hebei Medical University (CN), Third Hospital of Hebei Medical University (CN)

Openalex Percentile: Top 4%

Diabetes Treatment and Management

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.